Surgepays Valuation
| SURG Stock | USD 1.98 0.03 1.54% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Surgepays has a current Real Value of $4.63 per share. The regular price of the company is $1.98. Our model measures the value of Surgepays from inspecting the company fundamentals such as Shares Outstanding of 20.16 M, return on equity of -0.0519, and Operating Margin of (0.72) % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Surgepays' valuation include:
Price Book 1.131 | Enterprise Value 18.3 M | Enterprise Value Ebitda 1.0024 | Price Sales 0.3319 | Forward PE 8 |
Undervalued
Today
Please note that Surgepays' price fluctuation is risky at this time. Calculation of the real value of Surgepays is based on 3 months time horizon. Increasing Surgepays' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Surgepays stock is determined by what a typical buyer is willing to pay for full or partial control of Surgepays. Since Surgepays is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgepays Stock. However, Surgepays' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.98 | Real 4.63 | Target 13.0 | Hype 2.04 | Naive 2.24 |
The real value of Surgepays Stock, also known as its intrinsic value, is the underlying worth of Surgepays Company, which is reflected in its stock price. It is based on Surgepays' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Surgepays' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Surgepays helps investors to forecast how Surgepays stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgepays more accurately as focusing exclusively on Surgepays' fundamentals will not take into account other important factors: When choosing an evaluation method for Surgepays, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Surgepays Cash |
|
Surgepays Valuation Trend
Comparing Surgepays' enterprise value against its market capitalization is a good way to estimate the value of Surgepays uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Surgepays Total Value Analysis
Surgepays is at this time projected to have valuation of 18.27 M with market capitalization of 37.5 M, debt of 5.44 M, and cash on hands of 8.7 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Surgepays fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.27 M | 37.5 M | 5.44 M | 8.7 M |
Surgepays Investor Information
About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.13. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgepays has Price/Earnings To Growth (PEG) ratio of 0.53. The entity recorded a loss per share of 1.18. The firm had not issued any dividends in recent years. Surgepays had 1:50 split on the 2nd of November 2021. Based on the key indicators related to Surgepays' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Surgepays is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in January.Surgepays Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Surgepays has an asset utilization ratio of 327.11 percent. This implies that the Company is making $3.27 for each dollar of assets. An increasing asset utilization means that Surgepays is more efficient with each dollar of assets it utilizes for everyday operations.Surgepays Ownership Allocation
Surgepays shows a total of 20.16 Million outstanding shares. Surgepays maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Surgepays Profitability Analysis
The company reported the previous year's revenue of 137.14 M. Net Income was 20.62 M with profit before overhead, payroll, taxes, and interest of 13.47 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Surgepays' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Surgepays and how it compares across the competition.
About Surgepays Valuation
The stock valuation mechanism determines Surgepays' current worth on a weekly basis. Our valuation model uses a comparative analysis of Surgepays. We calculate exposure to Surgepays's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Surgepays's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 35.6 M | 37.4 M | |
| Pretax Profit Margin | 0.13 | 0.14 | |
| Operating Profit Margin | 0.14 | 0.14 | |
| Net Profit Margin | 0.15 | 0.16 | |
| Gross Profit Margin | 0.26 | 0.27 |
Surgepays Growth Indicators
Investing in growth stocks can be very risky. If the company such as Surgepays does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 14.9 M | |
| Quarterly Earnings Growth Y O Y | -0.777 | |
| Forward Price Earnings | 8 |
Surgepays Current Valuation Indicators
Valuation refers to the process of determining the present value of Surgepays and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Surgepays we look at many different elements of the entity such as Surgepays's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Surgepays, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Surgepays' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Surgepays' worth.Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |